Cryptocurrencies declined more than 1 percent in
Mirati Therapeutics Falls 5% After Bristol Myers Squibb Decides To Acquire It
Shares of Mirati Therapeutics, Inc. (MRTX) are
Q3's 2nd Worst, 2023's Best Asset Class: Bitcoin, Says NYDIG
On October 6, Greg Cipolaro, Global Head of
Crypto Analyst Martin Leinweber Reveals Potential Catalysts for Next Crypto Bull Run
On 7 October 2023, Martin Leinweber, Digital
JPMorgan on Ethereum's Centralization and Lower Yields After Upgrades
According to CoinDesk, J.P. Morgan has released
Bitcoin Price Prediction: BitMEX Founder Projects BTC to Soar Up To $1 Million By 2026
In a recent interview, the enigmatic founder
Bitcoin Investment Strategy: Analyst Sets Hefty Exit Price
A crypto YouTuber has revealed his Bitcoin
Bitcoin Could Drop to $10K Amid Economic Uncertainties, Warns Bloomberg's Mike McGlone
Bloomberg Intelligence’s Senior Macro Strategist, Mike McGlone,
Markets Muted Ahead Of Jobs Data
Markets sentiment was more or less subdued
Vivos Therapeutics In Deals With Ormco, On Demand Orthodontist; Stock Up In Pre-market
Medical device and technology company Vivos Therapeutics,
Cryptos Whipsaw As Dollar Rises, Yields Surge
After a brilliant rally a day earlier,
Cryptos Surge Ahead Amidst ETF Frenzy, Bitcoin Jumps Above $28k
Cryptocurrencies rallied close to 3 percent whereas
QCP Capital's Analysis on Crypto Market's Q4 Rally and Risks
As the final quarter of 2023 kicks
Bloomberg's Jamie Coutts: Bitcoin as Debasement Hedge
Jamie Coutts, a crypto market analyst at
Markets Brace For Inflation, GDP Updates
Sentiment remains weak across world markets ahead
Fidelity Executive Explains Why Institutions May Prefer Ethereum Over Bitcoin
Chris Kuiper, the Director of Research at